Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis

US8318708B2 · kind B2 · utility

Assignees

• Salk Institute for Biological Studies · US
• The University of Sydney · AU

Inventors

• Ronald M. Evans · Village of La Jolla, US
• Michael Downes · Village of La Jolla, US
• Christopher Liddle · Chatswood, AU
• Nanthakumar Subramaniam · Parramatta, AU
• Caroline Flora Samer · Geneva, CH

Key dates

• Filing date: May 3, 2010
• Grant date: Nov 27, 2012
• Expiry date: May 3, 2030

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/085
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This application relates to methods of treating and ameliorating fibrosis, such as fibrosis of the pancreas. In particular, the application relates to methods of using a vitamin D receptor agonist (such as vitamin D, vitamin D analogs, vitamin D precursors, and vitamin D receptor agonists precursors) for the treatment of pancreatic fibrosis.